SCHEMBL2030236

SCHEMBL2030236

CSc1ccc(C(CCc2cc(C)c(OC(C)(C)C(=O)O)c(C)c2)OCCC2CCCCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.51
PPARG P37231 18/20 0.51
PPARD Q03181 18/20 0.51
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2033665 0.92 PPARA (0.46) PPARAPPARGPPARD
SCHEMBL2030235 0.85 PPARA (0.46) PPARAPPARGPPARDCYP1A2CYP2C9
SCHEMBL2028540 0.85 PPARA (0.48) PPARAPPARGPPARD
SCHEMBL2027126 0.84 PPARA (0.49) PPARAPPARGPPARD
SCHEMBL2030587 0.82 PPARA (0.51) PPARAPPARGPPARD
SCHEMBL2028542 0.82 PPARA (0.47) PPARAPPARGPPARD
SCHEMBL2029585 0.81 PPARA (0.49) PPARAPPARGPPARDCYP1A2CYP2C9
SCHEMBL2027940 0.78 PPARA (0.52) PPARAPPARGPPARDCYP1A2CYP2C9
SCHEMBL2030238 0.77 PPARD (0.43) PPARAPPARGPPARD
SCHEMBL16472954 0.74 PPARA (0.39) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046715-B1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2014-04-16 EP claimed
US-8258182-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-09-04 US claimed
US-20110136888-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2011-06-09 US claimed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US claimed
EP-2046715-B1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2014-04-16 EP disclosed
US-8258182-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-09-04 US disclosed
US-8258182-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-09-04 US disclosed
US-8258182-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-09-04 US disclosed
US-20110136888-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2011-06-09 US disclosed
US-20110136888-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2011-06-09 US disclosed
US-20110136888-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2011-06-09 US disclosed
WO-2007147879-A1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136888-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof DPP3, DPP4, CYP3A43 PPARA 16/4885PPARG 84/4885PPARD 15/4885
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof DPP3, DPP8, DPP4 PPARA 11/4885PPARG 56/4885PPARD 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.